23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Sanofi’s new rabies vaccine wins EU approval

Rabies attacks the central nervous system and is incurable once symptoms appear. Sanofi’s new rabies vaccine has now received EU approval, offering a longer shelf life and improved temperature stability compared with the company’s previous vaccines.
Advertisement

An estimated 59,000 people die from rabies each year, according to the World Health Organization (WHO). The disease is caused by a lyssavirus and is mainly transmitted through bites from infected animals. Once symptoms appear, rabies is almost always fatal and there is no effective treatment, according to the Swedish Public Health Agency.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.078|